PURPOSE: Adipose-derived stem cells (ADSC) are multipotent, safe, non-immunogenic and can differentiate into functional keratocytes in situ. The topical use of ADSC derived from human processed lipoaspirate was investigated for treating injured rat cornea. METHODS: A total of 19 rats were used. Six animals initially underwent corneal lesion experiments with 0.5 N NaOH (right eye) and 0.2 N (left). The 0.2 NaOH protocol was then used in 13 rats. All 26 eyes of 13 rats eyes received topical azythromycin bid for 3 d and divided into five treatment groups (n = 5 eyes/group), which included: control, stem cells, serum, stem + serum and adipose (raw human lipoaspirate). The four treatment groups received topical treatment three times daily for 3 d. Stem cells were isolated and harvested from human lipoaspirate. Topical eye drops were prepared daily with 1 × 10(5) cells/treatment. Fluorescein positive defect area and light microscope assessment was performed at 20, 28, 45, 50 and 74 h. Animals were sacrificed at 74 h for histological evaluation. Data were statistically analyzed for differences amongst groups. RESULTS: The stem cell-treated eyes had significantly smaller epithelial defects at each time point compared to control- and adipose-treated eyes (p < 0.05). This group showed slightly better epithelium healing than the serum and combined group, yet not significantly different. Histology showed that stem cell-treated corneas had complete re-epithelization, with less inflammatory cells and limited fibroblast activation structure compared with the control eyes. CONCLUSIONS: Our preliminary results show that topical treatment with ADSC seems to improve corneal wound healing.
PURPOSE: Adipose-derived stem cells (ADSC) are multipotent, safe, non-immunogenic and can differentiate into functional keratocytes in situ. The topical use of ADSC derived from human processed lipoaspirate was investigated for treating injured rat cornea. METHODS: A total of 19 rats were used. Six animals initially underwent corneal lesion experiments with 0.5 N NaOH (right eye) and 0.2 N (left). The 0.2 NaOH protocol was then used in 13 rats. All 26 eyes of 13 rats eyes received topical azythromycin bid for 3 d and divided into five treatment groups (n = 5 eyes/group), which included: control, stem cells, serum, stem + serum and adipose (raw human lipoaspirate). The four treatment groups received topical treatment three times daily for 3 d. Stem cells were isolated and harvested from human lipoaspirate. Topical eye drops were prepared daily with 1 × 10(5) cells/treatment. Fluorescein positive defect area and light microscope assessment was performed at 20, 28, 45, 50 and 74 h. Animals were sacrificed at 74 h for histological evaluation. Data were statistically analyzed for differences amongst groups. RESULTS: The stem cell-treated eyes had significantly smaller epithelial defects at each time point compared to control- and adipose-treated eyes (p < 0.05). This group showed slightly better epithelium healing than the serum and combined group, yet not significantly different. Histology showed that stem cell-treated corneas had complete re-epithelization, with less inflammatory cells and limited fibroblast activation structure compared with the control eyes. CONCLUSIONS: Our preliminary results show that topical treatment with ADSC seems to improve corneal wound healing.
Authors: Sonia Reimondez-Troitiño; Ignacio Alcalde; Noemi Csaba; Almudena Íñigo-Portugués; María de la Fuente; Federico Bech; Ana C Riestra; Jesús Merayo-Lloves; María J Alonso Journal: Drug Deliv Transl Res Date: 2016-12 Impact factor: 4.617
Authors: Wei-Wei Xu; Li Huang; Kelvin K L Chong; Doreen S Y Leung; Benjamin F L Li; Zheng-Qin Yin; Yi-Fei Huang; Chi Pui Pang Journal: Int J Ophthalmol Date: 2017-01-18 Impact factor: 1.779
Authors: Rossana Domenis; Lara Lazzaro; Sarah Calabrese; Damiano Mangoni; Annarita Gallelli; Evgenia Bourkoula; Ivana Manini; Natascha Bergamin; Barbara Toffoletto; Carlo A Beltrami; Antonio P Beltrami; Daniela Cesselli; Pier Camillo Parodi Journal: Stem Cell Res Ther Date: 2015-01-05 Impact factor: 6.832
Authors: Fadi Ghieh; Rosalyn Jurjus; Amir Ibrahim; Alice Gerges Geagea; Hisham Daouk; Bassel El Baba; Sana Chams; Michel Matar; Wadih Zein; Abdo Jurjus Journal: Biomed Res Int Date: 2015-07-07 Impact factor: 3.411
Authors: Rossana Domenis; Natascha Bergamin; Giuseppe Gianfranceschi; Carlo Vascotto; Milena Romanello; Silvia Rigo; Giovanna Vagnarelli; Massimo Faggiani; Piercamillo Parodi; Mark R Kelley; Carlo Alberto Beltrami; Daniela Cesselli; Gianluca Tell; Antonio Paolo Beltrami Journal: PLoS One Date: 2014-02-19 Impact factor: 3.240